Statistics from Altmetric.com
- Akreos AO MI60
- diabetic retinopathy
- hydrophilic acrylic intraocular lens
- optic opacification
- anterior chamber
- optics and refraction
Recently, the approval of the hydrophilic acrylic intraocular lens (IOL; Akreos AO MI60; Bausch & Lomb, Rochester, New York) made microcoaxial surgery possible through a sub-2 mm incision. Although hydrophilic acrylic IOLs have proven to be highly biocompatible,1 several studies reported a late opacification of IOLs due to calcium deposits.2 3
The authors report five patients with calcium deposits on the anterior surface of Akreos AO MI60 IOLs which occurred after phacoemulsification and 23-gauge transconjunctival sutureless vitrectomy (TSV) for diabetic vitreous haemorrhage (VH). To our knowledge, opacification for this IOL design has not been reported before.
One of the authors (SYK) implanted the Akreos AO MI60 IOLs in 208 cases between November 2008 and December 2009. Eighty-nine cases had phacoemulsification and 23-gauge TSV for diabetic VH. The authors observed five patients (2.4%) with IOL opacification from the 208 cases. Clinical characteristics of the five patients who had IOL opacification are shown in table 1 …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.